The Center for Disease Control (CDC) estimates that about 1 in 12 people (about 25 million) have asthma, and the numbers are increasing every year. Consequently, about 40% of asthmatic patients who have nasal polyps and sinusitis are also allergic to aspirin.
As a result, in 2004 Nyack Hospital and John Bosso, M.D., Chief of Allergy and Immunology at Nyack Hospital created a new Aspirin-Desensitization Program. The first of its kind in the region, this program involves giving patients increasing doses to deter their body’s reactions to the medication in a controlled medical setting.
Since its inception, the program has grown dramatically and has successfully desensitized over 500 patients with Aspirin Exacerbated Respiratory Disease (AERD or Samter’s triad). Benefits include decreased nasal congestion, fewer nasal polyps, less sinus infections and asthma symptoms, reductions in the need for prednisone and sinus surgery procedures. In addition, most patients have an improvement in their sense of smell and overall quality of life.
For more information about aspirin desensitization and to set up a consultation, please call 845.353.9600.